Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Elena Pentsova, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator - Katharine McNeill, MD
NYU MEDICAL CENTER
Principal Investigator - Lisa DeAngelis, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator - Matthew Taylor, MD
Oregon Health and Sciences University
Principal Investigator - Timothy Chan, MD
Memorial Sloan Kettering Cancer Center
Principal Investigator - Walter Urba, MD, PhD
Providence Health & Services
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- New York University
New York, New York, United States
- Oregon Health and Sciences University
Portland, Oregon, United States
- Providence Cancer Center
Portland, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2010
- Primary completion
- 31 Jan 2025
- Completion
- 31 Jan 2026
- Last update posted
- 9 Sept 2025
- Registered enrollment
- 100
- Registry id
- NCT01107522
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.